These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 239485)

  • 41. [Interaction of acrylates with the microsomal oxidation system in the rat liver].
    Kotlovskiĭ IuV; Bekerev VE; Bachmanova GI; Ivanov VV
    Vopr Med Khim; 1985; 31(6):74-7. PubMed ID: 4090391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae.
    Brian WR; Srivastava PK; Umbenhauer DR; Lloyd RS; Guengerich FP
    Biochemistry; 1989 Jun; 28(12):4993-9. PubMed ID: 2669966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on drug metabolism and hepatic microsomes of rats and mice.
    Greig JB; De Matteis F
    Environ Health Perspect; 1973 Sep; 5():211-9. PubMed ID: 4752904
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of sulfhydryl reagents upon the activity of 40S ribosomal subunits.
    Tiryaki D; Uçer U; Bermek E
    Experientia; 1976 Oct; 32(10):1270-2. PubMed ID: 976437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for an inhibitory product-cytochrome P-450 complex generated during benzphetamine metabolism by liver microsomes.
    Werringloer J; Estabrook RW
    Life Sci; 1973 Nov; 13(10):1319-30. PubMed ID: 4148650
    [No Abstract]   [Full Text] [Related]  

  • 46. The activation of glucose dehydrogenase by p-chloromercuribenzoate.
    Bublitz C; Lawler CA
    Mol Cell Biochem; 1989 Apr; 86(2):101-6. PubMed ID: 2770707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of aromatic nitro compounds on oxidative metabolism by cytochrome P-450 dependent enzymes.
    Sternson LA; Gammans RE
    J Med Chem; 1976 Jan; 19(1):174-7. PubMed ID: 1246040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of inhibition in pathways of NADP.H2 and NAD.H2 oxidation in liver tissue microsomes].
    Archakov AI; Ahirnov GE; Karusina II
    Vopr Med Khim; 1975; 21(3):281-5. PubMed ID: 1902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between the reduction of oxygen, artificial acceptors and cytochrome P-450 by NADPH--cytochrome c reductase.
    Lyakhovich V; Mishin V; Pokrovsky A
    Biochem J; 1977 Nov; 168(2):133-9. PubMed ID: 202259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stoichiometric cooperation of NADPH and hexobarbital in hepatic microsomes during the catalysis of hydrogen peroxide formation.
    Hildebrandt AG; Heinemeyer G; Roots I
    Arch Biochem Biophys; 1982 Jul; 216(2):455-65. PubMed ID: 6810759
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug metabolism by an acetone powder from rat hepatic microsomes.
    Leber P; Bousquet WF
    Life Sci I; 1971 Sep; 10(18):1037-43. PubMed ID: 4399780
    [No Abstract]   [Full Text] [Related]  

  • 53. Measurement of substrate-induced oxygen uptake during microsomal drug oxidation using a gold micro-electrode.
    Wolf CR; Elcombe CR; Illing HP; Bridges JW; Nimmo-Smith RH; King LJ; Netter KJ
    Xenobiotica; 1975 Mar; 5(3):173-81. PubMed ID: 241154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting anxiety responses to halogenated glucocorticoid drugs using the hexobarbital sleep time test.
    Tseilikman OB; Kozochkin DA; Manukhina EB; Downey HF; Misharina ME; Komelkova MV; Nikitina AA; Golodnii SV; Dodohova MA; Tseilikman VE
    Stress; 2016 Jul; 19(4):390-4. PubMed ID: 27181454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide.
    Gergel D; Misík V; Riesz P; Cederbaum AI
    Arch Biochem Biophys; 1997 Jan; 337(2):239-50. PubMed ID: 9016819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate-dependent reduction of mammalian hepatic microsomal cytochrome b5: some properties of the enzyme system catalyzing the endogenous reduction of pyridine nucleotides.
    Kulkarni AP; Hodgson E
    Int J Biochem; 1982; 14(9):825-30. PubMed ID: 7128914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Onoda K; Sasajima M
    Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
    [No Abstract]   [Full Text] [Related]  

  • 58. Spin state control of the hepatic cytochrome P450 redox potential.
    Sligar SG; Cinti DL; Gibson GG; Schenkman JB
    Biochem Biophys Res Commun; 1979 Oct; 90(3):925-32. PubMed ID: 228675
    [No Abstract]   [Full Text] [Related]  

  • 59. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.
    Netter KJ; Illing HP
    Xenobiotica; 1974 Sep; 4(9):549-61. PubMed ID: 4372813
    [No Abstract]   [Full Text] [Related]  

  • 60. Proceedings: Monooxygenase activity and nicotinamide nucleotide systems in perfused rat liver.
    Sies H
    Z Klin Chem Klin Biochem; 1975 Aug; 13(8):376. PubMed ID: 3044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.